Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter
YouTube

42° Sunny
- Broken Bow, NE (68822)
  Today
  
  Mainly sunny to start, then a few afternoon clouds. High around 55F. NW winds shifting to S at 10 to 15 mph..
  
  Tonight
  
  Partly cloudy. Low 28F. Winds ESE at 10 to 20 mph.
  
  Updated: March 13, 2026 @ 11:32 am
- Full Forecast

Site search

Home
News
- Local News
Sports
Obituaries
Photos
Videos
e-Edition
Classifieds
- Legal Notices
Business Directory

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Qiagen N.V. Common Shares (NY:QGEN)

41.03 -0.09 (-0.22%)

Streaming Delayed Price Updated: 1:50 PM EDT, Mar 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Qiagen N.V. Common Shares

< Previous 1 2 3 4 5 6 7 8 Next >

QIAGEN Announces 20-F Annual Report Filing for 2021 Results

March 14, 2022

From QIAGEN N.V.

Via Business Wire

Death Cross Looms Over Qiagen Investors ↗

February 17, 2022

If history is any guide, there may be trouble ahead for shares of Qiagen (NYSE:QGEN). A so-called "death cross" has formed on its chart and, not surprisingly, this could be...

Via Benzinga

The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In ↗

February 09, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Qiagen Q4 Earnings Beat Expectations On High Demand For COVID-19 Tests, Issues FY22 Guidance ↗

February 09, 2022

Qiagen N.V. (NYSE: QGEN)

Via Benzinga

Qiagen: Q4 Earnings Insights ↗

February 08, 2022

Qiagen (NYSE:QGEN) reported its Q4 earnings results on Tuesday, February 8, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Qiagen beat estimated earnings by...

Via Benzinga

QIAGEN beats outlook for fourth quarter and full-year 2021, delivers 22% CER full-year sales growth from non-COVID products

February 08, 2022

From QIAGEN N.V.

Via Business Wire

The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar ↗

February 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Qiagen's Earnings: A Preview ↗

February 07, 2022

Qiagen (NYSE:QGEN) is set to give its latest quarterly earnings report on Tuesday, 2022-02-08. Here's what investors need to know before the announcement. Analysts estimate that Qiagen will likely...

Via Benzinga

Earnings Scheduled For February 8, 2022 ↗

February 08, 2022

Companies Reporting Before The Bell • Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion.

Via Benzinga

QIAGEN’s New Generation of QuantiFERON TB Test Gains Chinese Approval and Renewed WHO Recommendation

February 07, 2022

From QIAGEN N.V.

Via Business Wire

The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More ↗

February 06, 2022

Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...

Via Benzinga

QIAGEN’s Commitment to LGBTQ+ and Gender Equality Recognized by Human Rights Campaign and Bloomberg Indexes

January 27, 2022

From QIAGEN N.V.

Via Business Wire

QIAGEN Completes U.S. Federal Contract to Equip Local Public Health Authorities with QIAcuity Digital PCR System for COVID-19 Surveillance

January 25, 2022

From QIAGEN N.V.

Via Business Wire

QIAGEN N.V. to release results for Q4 2021 and Full-Year of 2021

January 19, 2022

From QIAGEN N.V.

Via Business Wire

QIAGEN Launches QIAwave Portfolio of Environmentally Friendly Products

January 18, 2022

From QIAGEN N.V.

Via Business Wire

What Does Qiagen's Debt Look Like? ↗

January 13, 2022

Over the past three months, shares of Qiagen (NYSE:QGEN) moved lower by 5.06%. Before we understand the importance of debt, let us look at how much debt Qiagen has. Qiagen...

Via Benzinga

QIAGEN expands QIAstat-Dx syndromic testing menu and announces launch plans for new QIAstat-Dx Rise higher-throughput version

January 10, 2022

From QIAGEN N.V.

Via Business Wire

QIAGEN Strengthens Growing Portfolio of Applications for Its Digital PCR Platform QIAcuity With New Collaborations

January 07, 2022

From QIAGEN N.V.

Via Business Wire

QIAGEN Expands QuantiFERON Portfolio in the Fight Against TB

January 06, 2022

From QIAGEN N.V.

Via Business Wire

Free COVID Tests: What Stocks Will Benefit? ↗

December 23, 2021

The government hasn’t announced yet what company or companies it will be buying from, but there are several businesses involved in producing these kits.

Via Talk Markets

The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO ↗

December 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus FDA Committee Votes Against Recommending Approval Of Kidney Disease Drug...

Via Benzinga

QIAGEN and Denovo Biopharma Partner to Develop Companion Diagnostic Test for the Treatment of Diffuse Large B-Cell Lymphoma (DLBCL)

December 09, 2021

From QIAGEN N.V.

Via Business Wire

QIAGEN Launches CE-marked Version of QuantiFERON® SARS-CoV-2 to Assess T-cell Response to COVID-19

December 02, 2021

From QIAGEN N.V.

Via Business Wire

QIAGEN and DiaSorin widen access to latent TB testing in the U.S. with FDA approval of QuantiFERON®-TB Gold Plus assay on LIAISON® XS

November 29, 2021

From QIAGEN N.V.

Via Business Wire

Qiagen Says Its COVID-19 PCR Tests Can Detect The New South African Variant ↗

November 26, 2021

Qiagen N.V. (NYSE:QGEN) announced that its polymerase c...

Via Benzinga

Rising Test Accuracy Standards Needed as On-Site Demand for Covid-19 Testing Increases

November 09, 2021

FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 9, 2021 – USA News Group – After the launch of US President Joe Biden’s pushing of mandatory vaccination/testing in the...

Via FinancialNewsMedia

QIAGEN Commits to Reduce Carbon Emissions by Setting Science-Based Target to Reach Net Zero by 2050

November 08, 2021

From QIAGEN N.V.

Via Business Wire

Qiagen, Becton Dickinson Settle Patent Infringement Lawsuit For $53M ↗

November 08, 2021

Qiagen N.V. (NYSE: QGEN) settled with Becton Dickinson & Co (NYSE: BDX) a patent infringement lawsuit related to Qiagen's NeuMoDx 96 and NeuMoDx...

Via Benzinga

Topics Intellectual Property Lawsuit

QIAGEN and BD Settle Patent Infringement Lawsuit

November 05, 2021

From QIAGEN N.V.

Via Business Wire

Qiagen NV (QGEN) Q3 2021 Earnings Call Transcript ↗

November 04, 2021

QGEN earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Business
Entertainment
Local Events
Obituaries
Multimedia
Online Features

Services

Subscription Services
Pay Your Bill
Classifieds
Promote Your Event
Email Alerts
Place an Ad
Rack Locations
Search
Weather

custercountychief.com
311 South 10th Avenue
Broken Bow, NE 68822
Phone: 308-872-2471
Email: publisher@custercountychief.com

Facebook
Twitter
YouTube

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Broken Bow, NE (68822)

Today

Tonight

Qiagen N.V. Common Shares (NY:QGEN)

All News about Qiagen N.V. Common Shares

Sections

Services

Follow Us